Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.
The item "Current-Ratio" stands at 1.36 as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Current Ratio" stands at 1.36. This represents an increase of 17.84 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.70 percent compared to the value the year prior.
The 1 year change in percent is 6.70.
The 3 year change in percent is 18.91.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Current Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Current Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Current Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Current Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Current Ratio | 280,205,508,085.11 |